Tomas Hudlicky, Brock University chemist and a leading Canadian scientist, has developed a synthetic compound that appears to be capable of killing cancer cells while leaving healthy cells intact. Tomas has created and patented several variations of the compound pancratistatin, which has been tested on 20 different types of cancer cells by a research team at the University of Windsor. The team’s paper, “Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III,” appeared in the February issue of Scientific Reports. Read Cathy Majtenyi’s full article here
Brock scientist’s patented compound is turning out to be a cancer killer
Chemistry, Faculty of Mathematics and Science, Tomas Hudlicky
Categories: News
